| Product Code: ETC9950567 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Opioid Induced Constipation Drugs Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 United Kingdom (UK) Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.6 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of opioid-induced constipation in the UK |
4.2.2 Growing awareness about the need for effective treatment options |
4.2.3 Advancements in pharmaceutical research leading to the development of improved drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for opioid-induced constipation drugs |
4.3.2 Potential side effects associated with opioid-induced constipation medications |
4.3.3 Competition from alternative treatment options such as laxatives and dietary changes |
5 United Kingdom (UK) Opioid Induced Constipation Drugs Market Trends |
6 United Kingdom (UK) Opioid Induced Constipation Drugs Market, By Types |
6.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market, By Active Ingredients |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Active Ingredients, 2021- 2031F |
6.1.3 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Naloxegol, 2021- 2031F |
6.1.4 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.5 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Methylnaltrexone Bromide, 2021- 2031F |
6.1.6 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Docusate Sodium, 2021- 2031F |
6.1.7 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Over The Counter Medicines, 2021- 2031F |
6.2.3 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Prescription, 2021- 2031F |
6.2.4 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Natural Remedies, 2021- 2031F |
6.3 United Kingdom (UK) Opioid Induced Constipation Drugs Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Opioid Induced Constipation Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Opioid Induced Constipation Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Opioid Induced Constipation Drugs Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market Export to Major Countries |
7.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Imports from Major Countries |
8 United Kingdom (UK) Opioid Induced Constipation Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed opioid-induced constipation drugs |
8.2 Number of healthcare providers recommending opioid-induced constipation drugs |
8.3 Frequency of new drug launches or approvals in the opioid-induced constipation market |
9 United Kingdom (UK) Opioid Induced Constipation Drugs Market - Opportunity Assessment |
9.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
9.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United Kingdom (UK) Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United Kingdom (UK) Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Opioid Induced Constipation Drugs Market - Competitive Landscape |
10.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here